Drug product
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
D-0391-2025
Product summary
- Event
- Event 96756
- Status
- Ongoing
- Classification
- Class II
- Quantity
- 1190 Bottles
- Official record key
drug-enforcement:D-0391-2025
Official wording
Reason: cGMP Deviations
Code information: Lot #: L0224T, K1824M, K0124N, J1624V, J0824O, I2424E, I1024O, A0925F, L2324L, Exp: 7/31/2026.
Distribution pattern: Nationwide in the US
Derived failure modes
-
Manufacturing or process control
cGMP Deviations